In:
Annals of the New York Academy of Sciences, Wiley, Vol. 1232, No. 1 ( 2011-09), p. 114-139
Abstract:
The following on proton pump inhibitors (PPIs) and chemoprevention in relation to Barrett's esophagus includes commentaries on 48‐h pH monitoring, pH‐impedence, bile acid testing, dyspepsia, long/short segment Barrett's esophagus, nonerosive reflux disease (NERD), functional heartburn, dual‐release delivery PPIs, immediate‐release PPIs, long‐term PPI use, prokinetic agents, obesity, baclofen, nocturnal acid breakthrough, nonsteroidal anti‐inflammatory drugs (NSAIDs), and new PPIs.
Type of Medium:
Online Resource
ISSN:
0077-8923
,
1749-6632
DOI:
10.1111/nyas.2011.1232.issue-1
DOI:
10.1111/j.1749-6632.2011.06048.x
Language:
English
Publisher:
Wiley
Publication Date:
2011
detail.hit.zdb_id:
2834079-6
detail.hit.zdb_id:
211003-9
detail.hit.zdb_id:
2071584-5
SSG:
11
Permalink